Ascendis Pharma A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan. And we're continuing the 40th Annual Healthcare Conference today with Ascendis.
I'm joined by the company's CEO, Jan Mikkelsen, who's going to give a presentation, and then we're go into some Q&A. If you want to ask a question for the Q&A, you can click the blue, "ask a question" button on your screen, that will send it to me, and I can ask the management those questions after they present.
So with that, let me turn it over to Jan.
/- -
Thank you, Jess. It's always a pleasure to be here. Going to Slide #2. Today, I will be making some forward-looking statement. Please refer to the Risk Factors section of our most recent annual report Form 20-F, and our SEC filings for a list of factors that can cause actual results to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
